---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-007852"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2025-04-30T23:59:59+00:00"
generated_at: "2026-05-23T02:40:30.844047+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aspire Biopharma settles lender default claims, extends note maturities by 75 days

## Summary
- Lenders withdrew April 1 and April 9 default/acceleration notices; defaults deemed cured with no admission of fault.
- Maturities extended: Dec 13 note to Aug 15, 2025; Sep/Oct 2024 notes to Sep 10, 2025.
- Company to issue 625,000 shares to Blackstone and file S-1 registration by May 13, 2025.
- Lock-ups removed for Cobra, Blackstone, Thor; new leak-out restrictions based on trading volume through Aug 20, 2025.
- Lenders waived additional interest/penalties; company to pay up to $60,000 in deal costs added to principal.

## SEC filing metadata
- accession: 0001641172-25-007852
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2025-04-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000164117225007852/0001641172-25-007852-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000164117225007852/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-007852
- JSON: https://secwatch.observer/filing/0001641172-25-007852.json
- Plain text: https://secwatch.observer/filing/0001641172-25-007852.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.